Dr. Leora Fox keeps you up-to-date on HDSA research activities, recently published work about Huntington’s disease, historical moments in HD research and more.

October, 2020

Novartis Receives FDA Orphan Drug Designation to Study Potential HD Treatment

Posted on October 22, 2020

This week the pharmaceutical company Novartis announced that they had received special status from the FDA, known as Orphan Drug Designation,…

Read More

uniQure Trial Proceeds; Voyager Receives Regulatory Feedback

Posted on October 15, 2020

This week uniQure shared a press release stating that another two patients have entered their HD clinical trial. The drug, AMT-130, is an experimental gene therapy that…

Read More

HDBuzz Covers Virtual EHDN Conference

Posted on October 8, 2020

The European Huntington’s Disease Network hosts a yearly Plenary meeting to discuss the latest in HD science and clinical trials,…

Read More

HD Trialfinder: Study Updates

Posted on October 1, 2020

HDSA’s HD Trialfinder is an easy-to-use website that lists currently recruiting HD clinical trials in the United States and Canada. By answering some basic questions about…

Read More